<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
TNYA
Tenaya Therapeutics
$
()


  • Tenaya Therapeutics price target lowered by $1 at Canaccord, here's why

    3/20/2024 - 07:05am
  • Tenaya Therapeutics reports Q4 EPS (40c), consensus (44c)

    3/18/2024 - 16:11pm
  • Tenaya announces publication of TN-401 gene therapy preclinical data

    3/18/2024 - 08:35am
  • Tenaya Therapeutics announces publication of preclinical HDAC6 inhibitor data

    2/26/2024 - 08:38am
  • Tenaya Therapeutics prices 8.89M shares at $4.50 in underwritten offering

    2/8/2024 - 08:17am
  • Tenaya Therapeutics 8.888M share Secondary priced at $4.50

    2/8/2024 - 08:15am
  • The biotech stocks to own in 2024, according to Piper Sandler

    1/2/2024 - 12:13pm
  • Tenaya Therapeutics initiated with an Outperform at Leerink

    11/30/2023 - 06:12am
  • Tenaya Therapeutics price target raised to $19 from $17 at Canaccord

    11/10/2023 - 07:38am
  • Tenaya Therapeutics reports Q3 EPS (39c), consensus (47c)

    11/8/2023 - 16:53pm
  • Tenaya Therapeutics announces FDA clearance to begin testing of TN-401

    10/26/2023 - 08:40am
  • Tenaya Therapeutics management to meet virtually with Piper Sandler

    10/13/2023 - 09:43am
  • Tenaya Therapeutics presents clinical, preclinical data on TN-301 program

    10/9/2023 - 08:42am
  • Tenaya Therapeutics doses first patient in MyPeak-1 Phase 1b trial of TN-201

    10/5/2023 - 08:41am
  • Fly Intel: After-Hours Movers

    10/2/2023 - 18:43pm
dynamic_feed Breaking News